Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 136 AL 150

The impact of educational experiences on nursing students' knowledge and attitudes toward people with Alzheimer's disease: A mixed method study

Kimzey M, Mastel-Smith B, Alfred D.

Nurse Educ Today. 2016 Nov;46:57-63. doi: 10.1016/j.nedt.2016.08.031. Epub 2016 Aug 30.

Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology

Tosto G, Reitz C.

Mol Cell Probes. 2016 Dec;30(6):397-403. doi: 10.1016/j.mcp.2016.09.001. Epub 2016 Sep 13.

Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study

Chiaravalloti A, Fiorentini A, Francesco U, Martorana A, Koch G, Belli L, Toniolo S, Di Pietro B, Motta C, Schillaci O.

Medicine (Baltimore). 2016 Sep;95(37):e4206. doi: 10.1097/MD.0000000000004206.

Ocular indicators of Alzheimer's: exploring disease in the retina

Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M.

Acta Neuropathol. 2016 Dec;132(6):767-787. doi: 10.1007/s00401-016-1613-6. Epub 2016 Sep 19.

Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France

Hommet C, Novella JL, Auriacombe S, Vercelletto M, Berrut G, Belliard S, Desmidt T, Ceccaldi M.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):274-86. doi: 10.1684/pnv.2016.0629.

Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine

Desmidt T, Hommet C, Camus V.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621.

Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease

Osmanovic-Barilar J, Salkovic-Petrisi M.

Drugs Aging. 2016 Nov;33(11):787-808. doi: 10.1007/s40266-016-0407-9.

Multiple Targets for the Management of Alzheimer's Disease

Ahmad SS, Akhtar S, Jamal QM, Rizvi SM, Kamal MA, Khan MK, Siddiqui MH.

CNS Neurol Disord Drug Targets. 2016;15(10):1279-1289. doi: 10.2174/1871527315666161003165855.

Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities

Turner RC, Lucke-Wold BP, Robson MJ, Lee JM, Bailes JE.

Brain Inj. 2016;30(11):1279-1292. doi: 10.1080/02699052.2016.1193631. Epub 2016 Aug 11.

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.

Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1.

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease

Deardorff WJ, Grossberg GT.

Drug Des Devel Ther. 2016 Oct 3;10:3267-3279. doi: 10.2147/DDDT.S86463. eCollection 2016.

Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted

Itzhaki RF.

J Alzheimers Dis. 2016 Oct 18;54(4):1273-1281. doi: 10.3233/JAD-160607.

Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention

Levy B, Tsoy E, Gable S.

J Alzheimers Dis. 2016 Oct 18;54(4):1259-1272. doi: 10.3233/JAD-160309.

Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo

Cunha JP, Moura-Coelho N, Proença RP, Dias-Santos A, Ferreira J, Louro C, Castanheira-Dinis A.

Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2079-2092. doi: 10.1007/s00417-016-3430-y. Epub 2016 Jul 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias